Cargando…
The two-year impact of first generation protease inhibitor based antiretroviral therapy (PI-ART) on health-related quality of life
BACKGROUND: Protease inhibitor based antiretroviral therapy (PI-ART) was introduced in 1996 and has greatly reduced the incidence of HIV-related morbidity and mortality in the industrialised world. PI-ART would thus be expected to have a positive effect on health-related quality of life (HRQL). On t...
Autores principales: | Eriksson, Lars E, Bratt, Göran A, Sandström, Eric, Nordström, Gun |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1173133/ https://www.ncbi.nlm.nih.gov/pubmed/15871738 http://dx.doi.org/10.1186/1477-7525-3-32 |
Ejemplares similares
-
The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naïve and pre-treated but protease inhibitor (PI)- naïve hiv-infected patients
por: Knechten, H, et al.
Publicado: (2011) -
The HIV-1 late domain-2 S(40)A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility
por: Watanabe, Susan M., et al.
Publicado: (2016) -
Randomized Trial of Time-Limited Interruptions of Protease Inhibitor-Based Antiretroviral Therapy (ART) vs. Continuous Therapy for HIV-1 Infection
por: Firnhaber, Cynthia, et al.
Publicado: (2011) -
Trends in Antiretroviral Therapy and Prevalence of HIV Drug Resistance Mutations in Sweden 1997–2011
por: Bontell, Irene, et al.
Publicado: (2013) -
Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in São Paulo State, Brazil
por: Soldi, Giselle de Faria Romero, et al.
Publicado: (2019)